Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
Karol E. Watson, MD, PhD, Professor of Medicine/Cardiology, Co-director, UCLA Program in Preventative Cardiology; Director, UCLA Barbra Streisand Women's Heart Health Program, is a Cardiologist who worked...